Together these data indicate that signaling of secreted, soluble CLC/CLF through gp130 and JAK kinases is dispensible for resistance to 6-OHDA in neuroblastoma cells regardless of their differentiation state. The gene discussed is CRLF1; the disease is neuroblastoma.